Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Initial Study of a MOTHER-DAUGHTER SIDE-BRANCH ACCESS™ DES System for Bifurcation Lesions (First-in-Human, Feasibility Study)

NCT07649798 is registered in ClinicalTrials.gov with Advanced Bifurcation Systems Inc. as lead sponsor.

NCT NCT07649798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07649798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Initial Study of a MOTHER-DAUGHTER SIDE-BRANCH ACCESS™ DES System for Bifurcation Lesions (First-in-Human, Feasibility Study)
Lead sponsor
Advanced Bifurcation Systems Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 16, 2025
Completion date
November 19, 2028
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bifurcation coronary artery disease, coronary angioplasty, ischemic heart disease (ihd), percutaneous coronary intervention (pci)